Membrane-specific antibodies induced by liposomes can simultaneously bind to HIV-1 protein, peptide, and membrane lipid epitopes

Journal of Drug Targeting

Volumn 16, Issue 7-8, 2008, Pages 535-542

  Beck, Zoltan ^a   Karasavvas, Nicos ^b   Matyas, Gary R ^b   Alving, Carl R ^b  

^a HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

^b WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

Antibodies to cholesterol; Antibodies to glycolipids; Antibodies to phospholipids; HIV 1; Lipid A; Liposomes

Indexed keywords

AMINO ACID; ANTIGEN; CELL ANTIBODY; CHOLESTEROL; DIMYRISTOYLPHOSPHATIDYLCHOLINE; DIMYRISTOYLPHOSPHATIDYLGLYCEROL; EPITOPE; GALACTOSYLCERAMIDE; GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 140; GLYCOPROTEIN GP 160; GLYCOPROTEIN GP 41; LIPID A; LIPOSOME; MEMBRANE LIPID; MONOCLONAL ANTIBODY; PEPTIDE; PHOSPHATIDYLINOSITOL 4 PHOSPHATE; PHOSPHORYL LIPID A; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CROSS REACTION; DRUG BINDING SITE; DRUG PROTEIN BINDING; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNIZATION; LIPOSOMAL DELIVERY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUPERNATANT;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY FORMATION; BINDING SITES, ANTIBODY; CROSS REACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HIV ENVELOPE PROTEIN GP41; HIV-1; LIPOSOMES; MEMBRANE LIPIDS; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; PEPTIDES;

EID: 49149085628     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.1080/10611860802228517     Document Type: Article

References (28)

1. Allison, AG and Gregoriadis, G. (1974) Liposomes as immunological adjuvants. Nature, 252, p. 252.
2. Alving, CR (2006) Antibodies to lipids and liposomes: Immunology and safety. J Liposome Res, 16, pp. 157-166.
3. Alving, CR (2008) 4E10 and 2F5 monoclonal antibodies: Binding specificities to phospholipids, tolerance, and clinical safety issues. AIDS, 22, pp. 649-651.
4. Alving, CR and Rao, M. (2008) Lipid A and liposomes containing lipid A as antigens and adjuvants. Vaccine, 26, pp. 3036-3045.
5. Alving, CR and Wassef, NM (1999) Naturally occurring antibodies to cholesterol: A new theory of LDL cholesterol metabolism. Immunol Today, 20:8, pp. 362-366.
6. Alving, CR, Beck, Z., Karasavva, N., Matyas, GR and Rao, M. (2006) HIV-1, lipid rafts, and antibodies to liposomes: Implications for anti-viral-neutralizing antibodies. Mol Membr Biol, 23:6, pp. 453-465.
7. Beck, Z., Karasavvas, N., Tong, J., Matyas, GR, Rao, M. and Alving, CR (2007) Calcium modulation of monoclonal antibody binding to phosphatidylinositol phosphate. Biochem Biophys Res Commun, 354:3, pp. 747-751.
8. Binley, JM, Wrin, T., Korber, B., Zwick, MB, Wang, M., Chappey, C., Stiegler, G., Kunert, R., Zolla-Pazner, S., Katinger, H., Petropoulos, CJ and Burton, DR (2004) Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies. J Virol, 78:23, pp. 13232-13252.
9. Brown, BK, Karasavvas, N., Beck, Z., Matyas, GR, Birx, DL, Polonis, VR and Alving, CR (2007) Monoclonal antibodies to phosphatidylinositol phosphate neutralize human immunodeficiency virus type 1: Role of phosphate-binding subsites. J Virol, 81:4, pp. 2087-2091.
10. Buchacher, A., Predl, R., Strutzenberger, K., Steinfellner, W., Trkola, A., Purtscher, M., Gruber, G., Tauer, C., Steindl, F., Jungbauer, A. and Katinger, H. (1994) Generation of human monoclonal antibodies against HIV-1 proteins; electrofusion and Epstein-Barr virus transformation for peripheral blood lymphocyte immortalization. AIDS Res Hum Retroviruses, 10:4, pp. 359-369.
11. Burton, DR, Desrosiers, RC, Doms, RW, Koff, WC, Kwong, PD, Moore, JP, Nabel, GJ, Sodroski, J., Wilson, IA and Wyatt, RT (2004) HIV vaccine design and the neutralizing antibody problem. Nat Immunol, 5:3, pp. 233-236.
12. Fries, LF, Gordon, DM, Richards, RL, Egan, JE, Hollingdale, MR, Gross, M., Silverman, C. and Alving, CR (1992) Liposomal malaria vaccine in humans: A safe and potent adjuvant strategy. Proc Natl Acad Sci U S A, 89:1, pp. 358-362.
13. Galfre, G. and Milstein, C. (1981) Preparation of monoclonal antibodies: Strategies and procedures. Methods Enzymol, 73, pp. 3-46.
14. Garcon, N., Chomez, P. and Van Mechelen, M. (2007) GlaxoSmithKline Adjuvant Systems in vaccines: Concepts, achievements and perspectives. Expert Rev Vaccines, 6:5, pp. 723-739.
15. Haynes, BF, Fleming, J., Clair, EW, Katinger, H., Stiegler, G., Kunert, R., Robinson, J., Scearce, RM, Plonk, K., Staats, HF, Ortel, TL, Liao, HX and Alam, SM (2005) Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies. Science, 308:5730, pp. 1906-1908.
16. Haynes, BF and Alam, SM (2008) HIV-1 hides an Achilles' heel in virion lipids. Immunity, 28:1, pp. 10-12.
17. Karasavvas, N., Beck, Z., Tong, J., Matyas, GR, Rao, M., McCutchan, FE, Michael, NL and Alving, CR (2008) Antibodies induced by liposomal protein exhibit dual binding to protein and lipid epitopes. Biochem Biophys Res Commun, 366:4, pp. 982-987.
18. Kumar, A., Arora, R., Kaur, P., Chauhan, VS and Sharma, P. (1992) "Universal" T helper cell determinants enhance immunogenicity of a Plasmodium falciparum merozoite surface antigen peptide. J Immunol, 148:5, pp. 1499-1505.
19. Kundi, M. (2007) New hepatitis B vaccine formulated with an improved adjuvant system. Expert Rev Vaccines, 6:2, pp. 133-140.
20. Matyas, GR, Wassef, NM, Rao, M. and Alving, CR (2000) Induction and detection of antibodies to squalene. J Immunol Methods, 245:1, pp. 1-14.
21. Rao, M., Matyas, GR, Vancott, TC, Birx, DL and Alving, CR (2004) Immunostimulatory CpG motifs induce CTL responses to HIV type I oligomeric gp140 envelope protein. Immunol Cell Biol, 82:5, pp. 523-530.
22. Schuster, BG, Neidig, M., Alving, BM and Alving, CR (1979) Production of antibodies against phosphocholine, phosphatidylcholine, sphingomyelin, and lipid A by injection of liposomes containing lipid A. J Immunol, 122:3, pp. 900-905.
23. Sun, ZY, Oh, KJ, Kim, M., Yu, J., Brusic, V., Song, L., Qiao, Z., Wang, JH, Wagner, G. and Reinherz, EL (2008) HIV-1 broadly neutralizing antibody extracts its epitope from a kinked gp41 ectodomain region on the viral membrane. Immunity, 28:1, pp. 52-63.
24. Uemura, K., Nicolotti, RA, Six, HR and Kinsky, SC (1974) Antibody formation in response to liposomal model membranes sensitized with N-substituted phosphatidylethanolamine derivatives. Biochemistry., 13:8, pp. 1572-1578.
25. Vandepapeliere, P., Horsmans, Y., Moris, P., Van Mechelen, M., Janssens, M., Koutsoukos, M., Van Belle, P., Clement, F., Hanon, E., Wettendorff, M., Garcon, N. and Leroux-Roels, G. (2008) Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers. Vaccine, 26:10, pp. 1375-1386.
26. Wassef, NM, Roerdink, F., Swartz Jr, GM, Lyon, JA, Berson, BJ and Alving, CR (1984) Phosphate-binding specificities of monoclonal antibodies against phosphoinositides in liposomes. Mol Immunol, 21:10, pp. 863-868.
27. Wassef, NM, Alving, CR and Richards, RL (1994) Liposomes as carriers for vaccines. Immunomethods, 4:3, pp. 217-222.
28. Zwick, MB, Labrijn, AF, Wang, M., Spenlehauer, C., Saphire, EO, Binley, JM, Moore, JP, Stiegler, G., Katinger, H., Burton, DR and Parren, PW (2001) Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41. J Virol, 75:22, pp. 10892-10905.